Acute and Critical Care 2019 November 34(4):269-275 Acute and Critical Care https://doi.org/10.4266/acc.2019.00591 | pISSN 2586-6052 | eISSN 2586-6060 Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study Yong Jun Jeon1, Jong Wan Kim2, SungGil Park2, Dong Woo Shin2 1Department of Surgery, Chinjujeil Hospital, Jinju; 2Department of Surgery, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea Background: Snakebite can cause various complications, including coagulopathy. The clinical features of snakebite-associated coagulopathy differ from those of disseminated intravascu- Original Article lar coagulation (DIC) caused by other diseases and its treatment is controversial. Methods: We retrospectively reviewed the medical records of patients hospitalized for snake- Received: June 20, 2019 Revised: August 28, 2019 bite between January 2006 and September 2018. Accepted: August 28, 2019 Results: A total of 226 patients were hospitalized due to snakebite. Their median hospital stay was 4.0 days (interquartile range, 2.0 to 7.0 days). Five patients arrived at hospital with Corresponding author shock and one patient died. Twenty-one patients had overt DIC according to the Internation- Yong Jun Jeon al Society of Thrombosis and Hemostasis scoring system. Two patients developed major bleed- Department of Surgery, Chinjujeil Hospital, 885 Jinju-daero, Jinju ing complications. Initial lower cholesterol level at presentation was associated with the de- 52709, Korea velopment of overt DIC. International normalization ratio (INR) exceeding the laboratory’s Tel: +82-55-750-7123 measurement limit was recorded as late as 4 to 5 days after the bite. Higher antivenom doses Fax: +82-55-750-7574 (≥18,000 units) and transfusion of fresh frozen plasma (FFP) or cryoprecipitate did not affect E-mail:
[email protected] prolonged INR duration or hospital stay in the overt DIC patients without bleeding.